{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Complicated+Urinary+Tract+Infections&page=2", "query": { "condition": "Complicated Urinary Tract Infections", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Complicated+Urinary+Tract+Infections&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-23T21:32:54.964Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01644643", "title": "Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infection", "Complicated Intra-abdominal Infection" ], "interventions": [ { "name": "Ceftazidime - Avibactam ( CAZ-AVI)", "type": "DRUG" }, { "name": "Best Available Therapy", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 345, "start_date": "2013-01", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2017-09-29", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 2, "location_summary": "Shreveport, Louisiana • Lima, Ohio", "locations": [ { "city": "Shreveport", "state": "Louisiana" }, { "city": "Lima", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01644643" }, { "nct_id": "NCT03357614", "title": "Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infections" ], "interventions": [ { "name": "Sulopenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1395, "start_date": "2018-09-18", "completion_date": "2019-12-14", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 15, "location_summary": "Bellflower, California • Chula Vista, California • La Mesa, California + 11 more", "locations": [ { "city": "Bellflower", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03357614" }, { "nct_id": "NCT03788967", "title": "Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infection", "Acute Pyelonephritis" ], "interventions": [ { "name": "TBPM-PI-HBr", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Dummy Infusion", "type": "DRUG" }, { "name": "Dummy tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spero Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1372, "start_date": "2019-06-03", "completion_date": "2020-05-27", "has_results": true, "last_update_posted_date": "2022-07-25", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 2, "location_summary": "La Mesa, California • Miami, Florida", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03788967" }, { "nct_id": "NCT00481689", "title": "Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Tract Infections" ], "interventions": [ { "name": "Cipro XR (Ciprofloxacin, BAYQ3939)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2004-05", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2009-06-26", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Cudahy", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00481689" }, { "nct_id": "NCT02753946", "title": "Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Urinary Tract Infection Symptomatic", "Acute Pyelonephritis", "Urinary Tract Infection Complicated" ], "interventions": [ { "name": "ZTI-01", "type": "DRUG" }, { "name": "Piperacillin-tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nabriva Therapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 465, "start_date": "2016-04", "completion_date": "2017-05-30", "has_results": true, "last_update_posted_date": "2019-03-07", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 6, "location_summary": "Pensacola, Florida • Augusta, Georgia • Columbus, Georgia + 3 more", "locations": [ { "city": "Pensacola", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Columbus", "state": "Georgia" }, { "city": "Boylston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02753946" }, { "nct_id": "NCT03687255", "title": "Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infections" ], "interventions": [ { "name": "cefepime/AAI101 combination", "type": "DRUG" }, { "name": "Piperacillin/tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allecra", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1043, "start_date": "2018-09-24", "completion_date": "2020-02-15", "has_results": false, "last_update_posted_date": "2020-03-10", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 6, "location_summary": "Anaheim, California • Buena Park, California • Tampa, Florida + 3 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Buena Park", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Butte", "state": "Montana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03687255" }, { "nct_id": "NCT06086626", "title": "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gram-Negative Bacterial Infections" ], "interventions": [ { "name": "Cefiderocol", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "3 Months", "sex": "ALL", "summary": "Up to 3 Months" }, "enrollment_count": 30, "start_date": "2024-03-14", "completion_date": "2025-03-31", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 2, "location_summary": "Little Rock, Arkansas • Durham, North Carolina", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06086626" }, { "nct_id": "NCT03697993", "title": "Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Tract Infection" ], "interventions": [ { "name": "Fosfomycin tromethamine", "type": "DRUG" }, { "name": "Levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 62, "start_date": "2018-11-07", "completion_date": "2019-10-24", "has_results": true, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 12, "location_summary": "Sylmar, California • Torrance, California • Decatur, Georgia + 9 more", "locations": [ { "city": "Sylmar", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03697993" }, { "nct_id": "NCT01110408", "title": "A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infections or Pyelonephritis" ], "interventions": [ { "name": "Doripenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Cefepime placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 41, "start_date": "2010-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 11, "location_summary": "Little Rock, Arkansas • Oakland, California • Orange, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110408" }, { "nct_id": "NCT00591240", "title": "A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urinary Tract Infections", "Bladder, Neurogenic" ], "interventions": [], "intervention_types": [], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2007-07", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2016-06-27", "last_synced_at": "2026-07-23T21:32:54.964Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591240" } ] }